diabetes%20mellitus%20(pediatric)
DIABETES MELLITUS (PEDIATRIC)
Diabetes mellitus (DM) is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both.
It can occur at any age and the earlier the onset, the more serious is the long-term damage, dysfunction and failure of various organs due to the chronic hyperglycemia with diabetes mellitus patients having <10 year in life span compared to non-DM patients.
Type 1 DM patients have complete insulin deficiency due to beta-cell destruction. It may be immune-mediated or idiopathic. More commonly occurs in children 7-15 year of age, but may occur at any age.
Type 2 DM patients have insulin resistance and relative insulin deficiency.
Neonatal DM is hyperglycemia that occurs in the first 6 months of life.

Diabetes Mellitus (Pediatric) Drug Information

Drug Information

Indication: NIDDM associated w/ an adapted diet in cases where dietary measures alone provide inadequate to control of blo...

Indication: NIDDM.

Indication: NIDDM (type 2) in adults when dietary measures, physical exercise & wt loss alone are not sufficient to co...

Indication: Type 2 DM inadequately controlled on metformin alone or who are already treated w/ combination of vildagliptin...

Indication: Adjunct therapy in adult w/ NIDDM when dietary measures, physical exercise & wt loss alone are insufficien...

Indication: Type 2 DM when not adequately controlled by dietary management & exercise alone. Monotherapy or in combina...

Indication: Monotherapy or in combination w/ other oral antidiabetic agents or w/ insulin for type 2 DM in adults when die...

Indication: Reduction in risk or delay of onset of type 2 DM in adults, overwt patients w/ impaired glucose & fasting ...

Indication: 2nd-line therapy when diet, exercise & initial treatment w/ sulfonylureas or metformin results in inadequa...

2  /  7
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Audrey Abella, 14 Oct 2020
Findings from the phase IIa T1GER study revealed the therapeutic potential of the monoclonal antibody golimumab for children and young adults with type 1 diabetes (T1D).